← SynDRA
pralmorelin
SynDRA canonical compound SYN0041755 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | GH1 | GH2 | GHRHR | GHSR |
| Mechanism of action | growth hormone releasing peptide ligand agonist |
All known targets
- GHSR
- GH1
- GH2
- GHRHR
- Ghsr
- PGD
Mechanisms of action (all sources)
- growth hormone releasing peptide ligand agonist
- PGD INHIBITOR
- GHSR AGONIST
Drug classes
Cross-references
Synonyms
- pralmorelin hydrochloride
- GHRP-2
- pralmorelin dihydrochloride
- KP-102
- GHRP
- KP-102D
- pralmorelin HCl
- Pralmoreline
- Pralmorelina
- Ghrp-2
- D-Alanyl-3-(2-naphthalenyl)-D-alanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-L-lysinamide
- KP 102
- UNII-E6S6E1F19M
- E6S6E1F19M
- WAY-GPA-748
- L-Lysinamide, D-alanyl-3-(2-naphthalenyl)-D-alanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-
- (2S)-6-amino-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2R)-2-aminopropanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamide
- Pralmorelin [INN]
- GHRP-2 Acetate/
- GHRP Kaken 100
- AC1OCF7D
- (2R)-2-methyl-4-deoxy and 2,4-dideoxy
- GHRP 2
- pralmorelina
- pralmoreline
- Ala-beta-Nal-Ala-Trp-Phe-Lys-NH2
- D-ALA-3-(2-NAPHTHYL)-D-ALA-ALA-TRP-D-PHE-LYS-NH2
- pralmorelinum
- RefChem:175716
- DTXCID501517409
- Pralmorelin (free base)
- Pralmorelin Diacetate Salt
- C45H55N9O6
- PRALMORELIN [MI]
- PRALMORELIN [WHO-DD]
- SCHEMBL424791
- GTPL1092
- KP-102LN
Look up pralmorelin in the interactive SynDRA portal →